Community/Retail

The entire medicines use process must be changed so as to minimise the environmental effects of pharmaceuticals, the International Pharmaceutical Federation says.

Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.

After the 2008 recession caused a decrease in state funding to public institutions, some pharmacy schools turned their attention to tuition increases and student giving.

A pharmacy robber not only left his fingerprints behind at a pharmacy-he also dropped his wallet containing his identification as he made his escape.

Hy-Vee has encouraged its customers to join its Hy-Vee Homefront initiative and help serve the men and women who have served America.

Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.

More and more pharmacists are unfortunately facing the challenge of unemployment.

Working at a retail pharmacy is filled with many challenges.

Nearly everyone has experienced a hiccup at least once in their lives.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.

In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.

Chlamydia, gonorrhea, and syphilis are on the rise for the first time since 2006, according to the US Centers for Disease Control and Prevention.

Skipping a flu shot may put patients at greater risk for flu-related pneumonia.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Mylan has launched a generic version of Teva Pharmaceuticals' Adderall in 5 mg, 7.5 mg, 10 mg, 12.5 mg, 20 mg, and 30 mg doses.

The FDA has approved Boehringer Ingelheim's oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.

As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.

Few technicians enter the pharmacy profession with aspirations of working as translators, but many find themselves playing that role the moment they step behind the drop-off counter.

Having trouble getting your hands on FluMist?

One of the most common questions I am asked as a pharmacist is how to convert from one anticoagulant to another.

What you eat and drink on Thanksgiving can significantly affect some medications.

Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.

Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.